On November 9, 2020 MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, reported that the Company’s management will participate in the following investor conferences in November and December (Press release, MacroGenics, NOV 9, 2020, View Source [SID1234570457]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Credit Suisse 29th Annual Virtual Healthcare Conference. MacroGenics’ management will participate in one-on-one meetings and provide a corporate overview on November 10, 2020 at 2:45 PM ET.
Stifel 2020 Virtual Healthcare Conference. MacroGenics’ management will participate in one-on-one meetings and participate in a fireside chat with the analyst on November 17, 2020 at 10:40 AM ET.
SVB Leerink Oncology 1×1 Day. MacroGenics’ management will participate in one-on-one meetings on November 19, 2020.
Evercore ISI 3rd Annual HealthCONx Virtual Conference. MacroGenics’ management will participate in one-on-one meetings and participate in a fireside chat with the analyst on December 2, 2020 at 3:55 PM ET.
Webcasts of the above presentations may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics’ website at View Source The Company will maintain archived replays of these webcasts on its website for 30 days after each conference.